R. M. de Figueiredo, J. M. Campagne et al.
m/z (%): 306 (20), 305 (100) [M+H]+; HRMS: m/z: calcd for C17H21O5:
305.1389; found: 305.1377 [M+H]+.
3. In order to determine the stereochemical outcome of the
domino cyclopropanation, single crystals were obtained
from lactone 5a, and the absolute configuration was deter-
mined by X-ray analysis to be 2S,3R, thus confirming the R
stereochemistry for compounds 3 (Figure 1).[20] Future work
within the group is aimed at expanding this concept to other
asymmetric reactions (e.g., a,b-disubstituted unsaturated al-
dehydes) as well as to use the isolated cyclopropanes in
order to prepare more elaborated scaffolds.
Cyclopropane 3b: 2,6-Lutidine: 78% yield, N-methylimidazole: 72%
yield; colorless oil; Rf =0.20 (pentane/Et2O 9:1); [a]2D5 =ꢀ9.7 (c=1.13,
CHCl3); HPLC (after derivatization to 8b (see Supporting Information):
CHIRALCEL OD-H (250ꢅ4.6 mm ID) n-hexane/iPrOH 99:1; flow rate:
1.0 mLminꢀ1, 258C, l=254 nm, tmajor =8.81, tminor =12.17 min); 1H NMR
(400 MHz, CDCl3): d=9.26 (s, 1H), 4.29–4.19 (m, 4H), 2.09 (d, J=
5.6 Hz, 1H), 1.89 (d, J=5.6 Hz, 1H), 1.35 (s, 3H), 1.29 ppm (m, 6H);
13C NMR (100 MHz, CDCl3): d=198.2, 167.2, 166.2, 62.2, 62.1, 42.2, 38.2,
24.2, 14.0, 13.9, 12.5 ppm; IR (film): n˜ =2983, 2940, 1731, 1448, 1370,
1333, 1231, 1110, 1020, 960, 862 cmꢀ1; MS (ESI): m/z (%): 301 (40), 275
(10), 230 (15), 229 (100) [M+H]+; HRMS: m/z: calcd for C11H17O5:
229.1076; found: 229.1075 [M+H]+.
Cyclopropane 3c: 2,6-Lutidine: 77% yield, N-methylimidazole: 72%
yield; colorless oil; Rf =0.30 (pentane/Et2O 9:1); [a]2D5 =ꢀ5.4 (c=1.115,
CHCl3); HPLC (CHIRALCEL OJ (250ꢅ4.6 mm ID) n-hexane/iPrOH
99.5:0.5; flow rate: 1.0 mLminꢀ1, 258C, l=200 nm, tmajor =10.26, tminor
=
12.65 min); 1H NMR (400 MHz, CDCl3): d=9.18 (s, 1H), 4.24–4.13 (m,
4H), 1.96 (m, 2H), 1.81 (d, J=5.6 Hz, 1H), 1.56 (m, 1H), 1.24 (m, 6H),
0.92 ppm (t, J=7.4 Hz, 3H); 13C NMR (100 MHz, CDCl3): d=197.9,
167.0, 166.6, 62.2, 62.1, 43.7, 42.3, 23.0, 19.9, 14.0, 13.9, 11.5 ppm; IR
(film): n˜ =2981, 2870, 1793, 1730, 1469, 1369, 1277, 1251, 1218, 1111,
1026 cmꢀ1; MS (ESI): m/z (%): 470 (10), 244 (15), 243 (100) [M+H]+,
197 (10); HRMS: m/z: calcd for C12H19O5: 243.1232; found: 243.1228
[M+H]+.
Figure 1. X-ray crystal structure of lactone 5a.[20]
Experimental Section
Cyclopropane 3d: 2,6-lutidine: 35% yield (conversion of the starting ma-
terial: 40%), N-methyl imidazole: 43% yield; colorless oil; Rf =0.35
(pentane/Et2O 9:1); [a]2D5 =ꢀ25.6 (c=0.975, CHCl3); HPLC (CHIRAL-
CEL OJ (250ꢅ4.6 mm ID) n-hexane/iPrOH 99.5:0.5; flow rate:
1.0 mLminꢀ1, 258C, l=200 nm, tmajor =8.11, tminor =9.15 min); 1H NMR
(400 MHz, CDCl3): d=9.54 (s, 1H), 4.20 (q, J=7.2 Hz, 2H), 4.12 (q, J=
7.2 Hz, 2H), 1.94 (d, J=5.2 Hz, 1H), 1.77 (h, J=7.0 Hz, 1H), 1.66 (d, J=
5.2 Hz, 1H), 1.25 (t, J=7.2 Hz, 3H), 1.22–1.18 (m, 6H), 1.08 ppm (d, J=
7.0 Hz, 3H); 13C NMR (100 MHz, CDCl3): d 198.1, 167.0, 166.8, 62.2,
61.9, 46.5, 43.2, 28.2, 23.2, 19.7, 19.1, 14.0, 13.9 ppm; IR (film): n˜ =2979,
General methods: Commercial reagents were used without purification.
Reactions were carried out in round-bottom flasks equipped with a mag-
netic stirring bar. TLC analysis of all reactions was performed on silica
gel 60 F254 TLC plates (using 2,4-dinitrophenylhydrazine stain for alde-
hydes and phosphomolybdic acid for the other compounds). Flash chro-
matography was carried out on silica gel 60 A (35–70 mm). Melting points
were determined with a Bꢄchi Melting Point B-540 unit. FT-IR spectra
were recorded with a Perkin–Elmer Spectrum 1000. 1H and 13C NMR
spectra were recorded with a Bruker Ultra shield 400 plus. 1H chemical
shifts are reported in delta (d) units in parts per million (ppm) relative to
the singlet at 7.26 ppm for CDCl3 (residual CHCl3). 13C chemical shifts
are reported in ppm relative to the central line of the triplet at 77.0 ppm
for CDCl3. Splitting patterns are designated as s, singlet; d, doublet; t,
triplet; q, quartet; h, heptet; m, multiplet; and br, broad and combina-
tions thereof. Optical rotations were measured with a Perkin–Elmer 341
polarometer. Low resolutions mass spectra were recorded on a Waters
QTof-I spectrometer using electrospray ionization. High resolution mass
spectra were obtained using the mass spectrometers operated by the Lab-
oratoire de Mesure Physique of University Montpellier 2.
2877, 1793, 1731, 1466, 1370, 1310, 1223, 1130, 1106, 1021, 926, 859 cmꢀ1
;
MS (ESI): m/z (%): 625 (20), 624 (40), 403 (20), 402 (100), 257 (40)
[M+H]+; HRMS: m/z: calcd for C13H21O5: 257.1389; found: 257.1382
[M+H]+.
Cyclopropane 3e: 2,6-Lutidine: 65% yield, N-methylimidazole: 58%
yield; colorless oil; Rf =0.40 (pentane/Et2O 9:1); [a]2D5 =+6.5 (c=1.075,
CHCl3); HPLC (CHIRALCEL OJ (250ꢅ4.6 mm ID) n-hexane/iPrOH
99.5:0.5; flow rate: 1.0 mLminꢀ1, 258C, l=200 nm, tmajor =7.24, tminor
=
8.87 min); 1H NMR (400 MHz, CDCl3): d=9.23 (s, 1H), 4.25–4.16 (m,
4H), 1.94–2.01 (m, 2H), 1.84 (d, J=5.6 Hz, 1H), 1.56–1.49 (m, 1H),
1.41–1.23 (m, 10H), 0.87 ppm (t, J=7.0 Hz, 3H); 13C NMR (100 MHz,
CDCl3): d=198.1, 167.0, 166.6, 62.1, 62.0, 42.8, 42.3, 29.3, 26.3, 23.1, 22.7,
14.0, 13.9, 13.8 ppm; IR (film): n˜ =2961, 2873, 1731, 1466, 1370, 1301,
1240, 1201, 1107, 1020, 908, 862 cmꢀ1; MS (ESI): m/z (%): 640 (20), 639
(50), 272 (15), 271 (100) [M+H]+; HRMS: m/z: calcd for C14H23O5:
271.1545; found: 271.1537 [M+H]+.
General procedure for the organocatalyzed asymmetric cyclopropana-
tion: The a-methylene aldehydes (1a–f) were prepared according to the
procedure described by Pihko.[16] To a solution of the a-substituted a,b-
unsaturated aldehydes (1a–g; 0.684 mmol, 1.2 equiv) and organocatalyst
(I; 37.0 mg, 0.114 mmol, 20 mol%) in EtOH (2.5 mL) were successively
added the additive (2,6-lutidine: 199 mL, 1.71 mmol, 3.0 equiv or N-meth-
ylimidazole: 227 mL, 2.85 mmol, 5.0 equiv) and diethyl bromomalonate
(2; 97.0 mL, 0.57 mmol, 1.0 equiv). The reaction mixture was stirred at
room temperature for the indicated time (see Table 2) and the solvent
was removed. The residue was purified by flash chromatography on silica
gel (pentane/Et2O) to afford the desired cyclopropane 3a–g.
Cyclopropane 3 f: 2,6-Lutidine: 66% yield, N-methylimidazole: 52%
yield; colorless oil; Rf =0.20 (pentane/Et2O 4:1); [a]2D5 =+16.6 (c=1.205,
CHCl3); HPLC (after derivatization to 8 f (see Supporting Information):
CHIRALCEL OJ (250ꢅ4.6 mm ID) n-hexane/iPrOH 99.5:0.5; flow rate:
1.0 mLminꢀ1, 258C, l=200 nm, tminor =33.39, tmajor =62.76 min); 1H NMR
(400 MHz, CDCl3): d=9.11 (s, 1H), 4.27–4.16 (m, 4H), 3.64 (s, 3H),
2.53–2.45 (m, 1H), 2.38–2.30 (m, 1H), 2.27–2.19 (m, 1H), 2.03 (d, J=
5.6 Hz, 1H), 1.97–1.89 (m, 2H), 1.26 ppm (m, 6H); 13C NMR (100 MHz,
CDCl3): d=197.2, 172.8, 166.7, 166.1, 62.4, 62.3, 51.6, 42.1, 41.7, 31.3,
23.0, 22.0, 13.9, 13.8 ppm; IR (film): n˜ =2985, 1731, 1440, 1370, 1235,
1108, 1019, 913, 861, 838 cmꢀ1; MS (ESI): m/z (%): 302 (20), 301 (100)
[M+H]+; HRMS: m/z: calcd for C14H21O7: 301.1287; found: 301.1284
[M+H]+.
Cyclopropane 3a: 2,6-Lutidine: 72% yield, N-methylimidazole: 75%
yield; colorless oil; Rf =0.25 (pentane/Et2O 9:1); [a]2D5 =+21.6 (c=1.205,
CHCl3); HPLC (CHIRALCEL OD-H (250ꢅ4.6 mm ID) n-hexane/
iPrOH 99:1; flow rate: 1.0 mLminꢀ1
t
,
258C, l=254 nm,
tmajor =10.92,
minor =13.85 min); 1H NMR (400 MHz, CDCl3): d=9.26 (s, 1H), 7.29–
7.16 (m, 5H), 4.25–4.06 (m, 4H), 3.44 (d, J=15.4 Hz, 1H), 3.01 (d, J=
15.4 Hz, 1H), 2.09 (d, J=5.4 Hz, 1H), 2.05 (d, J=5.4 Hz, 1H), 1.29 (t,
J=7.2 Hz, 3H), 1.19 ppm (t, J=7.2 Hz, 3H); 13C NMR (100 MHz,
CDCl3): d=197.6, 166.7, 166.4, 137.7, 128.7 (2C), 128.4 (2C), 126.4, 62.3,
62.2, 42.8, 42.4, 31.5, 23.5, 13.9, 13.8 ppm; IR (film): n˜ =3030, 2983, 2938,
1731, 1497, 1454, 1370, 1252, 1183, 1108, 1017, 863, 699 cmꢀ1; MS (ESI):
Cyclopropane 3g: 2,6-Lutidine: 81% yield; colorless oil; Rf =0.30 (pen-
tane/Et2O 4:1); [a]2D5 =ꢀ83.3 (c=1.14, CHCl3); HPLC (after derivatiza-
tion to 8g (see Supporting Information): CHIRALCEL OD-H (250ꢅ
7878
ꢃ 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2010, 16, 7875 – 7880